Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease
about
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritisEffects of combination therapy with celecoxib and doxycycline on neointimal hyperplasia and inflammatory biomarkers in coronary artery disease patients treated with bare metal stentsCardiovascular effects of selective cyclooxygenase-2 inhibitors.Selective COX-2 inhibitors and risk of myocardial infarction.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Cyclooxygenase products and atherosclerosisCOX-1 and vascular disease.Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.The cardiovascular safety of celecoxib.Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited.Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain-A 6 months prospective longitudinal study
P2860
Q21195404-A786C860-71F3-4BA6-B1FA-FF717C07D495Q35648213-7161A207-2DBD-4536-B5F5-4BCD5A36770CQ35777371-79B50C77-D100-4FAB-9895-3243AF7969AAQ36173750-FF643079-DC9F-46E0-A413-80675B0E7844Q36752124-40712C50-25BE-4E01-8C8C-1D6866220496Q37071164-9D08B321-71C4-4E72-8D6F-D003AFD38C8DQ37530433-3463C38C-92FB-479E-99A9-51629A68A2BFQ38011618-BDE21823-EA13-4BB5-AB67-0D926FF3864CQ40377176-C81570AE-89E0-433B-B4DC-9D8D8CF74E7FQ46743815-4F24552B-BDF8-47E1-8C3D-D161D925259FQ47372560-2A98ED39-4696-48B4-AC10-43BEFE21BFEFQ51493196-95EB1729-18C0-492A-B9BF-CBBE102FC7E6Q57192479-5E531B59-E8C0-4FC8-889E-F0EFC2A42404
P2860
Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@ast
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@en
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@nl
type
label
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@ast
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@en
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@nl
prefLabel
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@ast
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@en
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@nl
P2093
P1476
Effect of cyclooxygenase-2 inh ...... s with coronary artery disease
@en
P2093
Bassam A Nassar
Karen Giddens
Lawrence M Title
Matthew J McQueen
Michele M McInerney
P304
P356
10.1016/J.JACC.2003.05.006
P407
P577
2003-11-19T00:00:00Z